What is the most common virus transmitted by blood transfusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hepatitis C is the Most Common Virus Transmitted by Blood Transfusion

The answer is C. Hepatitis C (HCV) is historically the most common virus transmitted by blood transfusion, accounting for the majority of post-transfusion hepatitis cases. 1

Historical Transmission Rates and Evidence

  • HCV transmission rates exceeded 20% in the 1960s before modern screening methods were implemented 1
  • Before donor screening implementation, approximately 10% of transfusion recipients developed non-A, non-B hepatitis (later identified primarily as HCV) 1
  • Studies demonstrated that 90% of post-transfusion hepatitis was not caused by hepatitis A or B viruses, but rather by HCV 1

Comparison with Other Transfusion-Transmitted Viruses

  • Hepatitis B (HBV) transmission rates were reduced to 0.3%-0.9% per transfusion recipient by the mid-1970s due to improved screening 1
  • While HIV, HTLV, HBV, and HCV are all important transfusion-transmitted viruses, HCV has historically been the most common 2
  • The risk of transmission for these viruses has been dramatically reduced to between one and four per million blood components transfused in the USA 2

Risk Reduction Measures

  • The shift from paid to volunteer blood donors contributed significantly to reducing transmission rates 1
  • Implementation of multiple screening methods has dramatically reduced HCV transmission:
    • Anti-HCV antibody screening
    • Nucleic acid testing (NAT) for HCV
    • Surrogate markers like ALT and anti-HBc testing 1

Current Screening Recommendations

  • The European Association for the Study of the Liver (EASL) recommends that blood donor services screen blood donors for hepatitis viruses using NAT, informed by local risk assessment 1
  • Patients with abnormal liver function tests after receiving blood products should be tested for HCV and other hepatitis viruses 1

Important Clinical Considerations

  • Despite modern screening methods, the risk is not zero, and false negatives can still occur 3
  • Current risks of transfusion-associated hepatitis due to HCV are approximately 1 in 125,000 per unit 4
  • Background rates of viral hepatitis now greatly exceed the risk of transmission via transfusion, so other sources of infection should be considered when evaluating a patient with hepatitis 4

References

Guideline

Hepatitis C Virus Transmission Through Blood Transfusion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Current risks of viral hepatitis from blood transfusions.

Journal of gastroenterology and hepatology, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.